Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Robot trainer aims to get stroke patients back on their feet

NCT ID NCT07034521

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new robot system (HIWIN MRG-P110) designed to help chronic stroke survivors improve their walking. The robot uses foot pedals to guide leg movements and can adjust how much it helps versus how much the patient must do on their own. Researchers will enroll 60 people who had a stroke 6 months to 3 years ago and compare two training modes: one where the robot does most of the work and one where it encourages active effort. The goal is to see which approach leads to better walking speed, balance, and brain activity changes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
HIWIN MRG-P110 robot system for gait training
What this could lead to
If successful, this could provide a new, more effective rehabilitation option for chronic stroke survivors to improve their walking ability.
What could go wrong
This is an early feasibility study with only 60 participants, so results may not apply to all stroke survivors. The robot is new and its benefits over standard therapy are unproven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

May 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged between 18 and 80 years old. * First-ever stroke, confirmed by brain CT or MRI, with onset between 6 months and 3 years prior to enrollment. * Walking ability classified as Functional Ambulation Category (FAC) level 1 to level 3. * Prior to the current stroke, the participant was an independent community ambulator without mobility impairments. Exclusion Criteria: * Presence of lower limb joint contractures, deformities, or severe spasticity (Modified Ashworth Scale score of 4). * Lower limb musculoskeletal conditions causing wounds, pain, inability to bear weight, or significant leg length discrepancy (\>2 cm after orthotic correction). * Known history of osteoporotic fractures in the thoracolumbar spine or hip joints. * Inability to use the exoskeleton device due to body size, including: Body weight \> 135 kg; Thigh length \< 36 cm or \> 48 cm; Calf length \< 42 cm or \> 58 cm * Cognitive or communication impairments that prevent understanding of study instructions or completion of questionnaires. * Acute infections or unstable vital signs. * Significant orthostatic hypotension or inability to maintain upright posture for more than 30 minutes. * Use of indwelling urinary catheter or tracheostomy. * Pregnant women. * Terminal illness with life expectancy less than six months. * Inability to attend 15 rehabilitation sessions and follow-up assessment at 3 months.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Rehabilitation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • National Taiwan University Hospital

    RECRUITING

    Taipei, Taipei, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.